August 2011 - Class Action Blog Archive
The U.S. Food and Drug Administration (FDA) has released a warning that high doses of the antidepressant drug Celexa (citalopram hydrobromide) present an increased risk of abnormal changes in the activity of the heart.
Reportedly, a lawsuit was filed against American Medical Systems (AMS) and Boston Scientific for vaginal mesh complications.
TrimBoard, a low-cost composite wood trim product, is reported to have a manufacturing defect, causing it to swell, decay and rot.
The FDA announced a possible link between prescription drug Actos and bladder cancer in patients taking the drug for a year or longer.
A probiotic supplement called Culturelle may not function as advertised, as its claims to help with digestive health and immune support have come into question.
The New York Times has reported that a study commissioned by the Food and Drug Administration (FDA) has strongly recommended a complete revision of the approval process for certain medical devices.
SSRI drugs (selective serotonin reuptake inhibitors) used to primarily treat depression fall into either category C or D. Category C drugs indicate that there may be a risk to fetal development based on studies conducted in animals, and category D drugs may cause harm to a fetus based on studies and research in humans.